Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Generic Drugs: World Market Outlook 2011-2021
Market Study
Published: September 2011
Pages: 139
Tables: For full details, please email deborahf@cmsinfo.com
From: GBP 1699.00 Buy Now!
Research from: Visiongain
Sector: Prescription Medicines
The world generics market has great potential to expand. Discover generic drug market revenues at total world and national levels. Through our research and analysis we aim to save you time and help in your decisions.
Which national markets have the greatest potential? See how generics markets in the US, Japan, leading EU countries, India, China, Turkey, Brazil, Mexico, South Korea and the Russian Federation can perform to 2021, finding potential revenues.
Also, discover commercial prospects for companies such as Teva, Sandoz, Mylan, Apotex, Hospira and Watson. Receive information you need for the generics industry and market.
In our report you receive discussions of regulations and opportunities. Assess prospects in off-patent drugs from 2011 onwards. Many more blockbusters will become vulnerable to generic competition.
Our report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.
Analysis with revenues, future growth rates, market shares, opinions and discussions
In our report you find revenue forecasts, growth rates, market shares, qualitative analyses (incl. SWOT) and opinions from our survey. You receive 84 tables and charts and two research interviews (see the table of contents).
Generic Drugs: World Market Outlook 2011-2021 shows you opportunities, challenges and revenue forecasts
Our report gives you the following advantages in particular:
• Find potential revenues to 2021 for the world generic drugs market, seeing the possibilities there
• Assess leading generics companies, discovering their activities and outlooks
• See market forecasts to 2021 for the US, Japan, the UK, Germany, France, Spain, Italy, Turkey, Brazil, Mexico, South Korea, the Russian Federation, India and China
• Review developments in the generics industry and its regulation, finding trends
• Investigate competition and opportunities influencing the industry and market
• Find out what will stimulate and restrain the industry and market from 2011
• View opinion from our survey, receiving full interview transcripts.
There, you find a distinctive mix of quantitative and qualitative analysis with independent predictions. We tackle crucial questions for generic drugs, helping you to stay ahead.
Companies Listed
Abbott Laboratories
Aché Laboratórios Farmacêuticos
Actavis
Altra Investments
Amgen
Andrx Corporation
Apotex
APP Pharmaceuticals
Arrow Group
Asociación Española de Fabricantes de Sustancias y Especialidades Farmacéuticas Genéricas (AESEG)
Aspen
Assogenerici - Associazione Nazionale Industrie Farmaci Generici
AstraZeneca
Aurobindo
Aurobindo Pharma
Barr Pharmaceuticals
Bayer HealthCare
Bedford Laboratories
Beijing MedPharm
Bioniche Pharma Holdings
Blue Cross Blue Shield Association (BCBSA)
BMP Sunstone
Boehringer Ingelheim
Bristol-Myers Squibb
British Generics Manufacturers Association (BGMA)
Cangene Corporation
Celltrion
Centers for Medicare and Medicaid Services
Cephalon
Chon Kun Dang
Cipla
Claris Lifesciences
CoGenesys
Congressional Budget Office (CBO)
Corporación Infarmasa [Peru]
Daiichi Sankyo
Dey Pharma
DOC Generici
Dr. Reddy's Laboratories
Ebewe Pharma
Eden Biodesign
Egis
Eisai Pharmaceuticals
Eli Lilly
EMS Sigma Pharma
Eon Labs
Eurofarma Laboratorios
European Commission (EC)
European Court of Justice
European Generic Medicines Association (EGA)
European Medicines Agency (EMA/EMEA)
European Union (EU)
Famy Care
Farmacia del Ahorro
Farmacias Similares
Federal Trade Commission (FTC)
Food and Drug Administration (US FDA)
Fuji Pharma
Gedeon Richter
Genentech
Generic Pharmaceutical Association (GPhA)
German Association of Pharmacists (ABDA)
GlaxoSmithKline (GSK)
Glenmark Pharmaceuticals
Greenstone (Pfizer)
Healthcare Economics LLC
H. Lundbeck
Hospira
Hospira Healthcare India
Intas Biopharmaceuticals
IVAX
Javelin Pharmaceuticals
Johnson & Johnson
Jubilant Organosys
Kowa Pharmaceuticals
Krka
Laboratorios Best
Laboratorios Kendrick
Lareq Pharma
Lek Pharmaceuticals
Lupin Pharmaceuticals
MasterLek
Matrix
Matrix Laboratories
Mayne Pharma
Medi-Mart
Medley Pharmaceuticals
Merck & Co.
Merck KGaA
Ministry of Health, Labour and Welfare (Japan)
Mundipharma International
Mylan Institutional
Mylan Pharmaceuticals
Mylan Seiyaku
National Health Service (UK NHS)
Nichi-iko Pharmaceutical
Nippon Chemiphar
Novartis
NOVN. V Hexal
Onco Therapies
Orchid Chemicals & Pharmaceuticals
Oriel Therapeutics
Pfizer
Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmstandard
Piramal Healthcare
Pliva
Purdue Pharma
Ranbaxy Laboratories
Ratiopharm
Roche
Samsung
Sanborns
Sandoz
Sanofi (formerly sanofi-aventis)
Sawai Pharmaceuticals
Shire Pharmaceuticals
Sigma Pharmaceuticals
SK Chemicals
Stada Arzneimittel AG
Strides Arcolab
Sun Pharmaceuticals
Taisho Pharmaceutical Industries
Taiyo Pharmaceuticals
Takeda Pharmaceutical Company
Tecnofarma
Teva Pharmaceutical Industries
The Rohatyn Group
Theramex
Topgen
Towa Pharmaceutical
UCB
UDL Laboratories
UK Department of Health
Veropharm
Wal-Mart
Warner Chilcott
Watson Laboratories
Watson Pharmaceuticals
Wockhardt
World Trade Organisation (WTO)
Wyeth
Zentiva
Zydus Cadila